Security key
68235C107
Oncocyte Corporation - Common Shares, No Par Value (OCX)
CUSIP: 68235C107
Q4 2024 13F Holders as of 31 Dec 2024
- Security type / class
- Equity / Common Shares, No Par Value
- Total 13F shares
- 47,078
- Total 13F value
- $112,046
- Share change
- -12,275
- SEC-reported price per share
- $2.38
- Number of holders
- 1
- Value change
- -$29,215
- Number of sells
- 1
- Shares outstanding
- 28,495,649
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2024
Institutions
1
Top holders
1
OCX full security history
Ownership snapshot
Full 13F holder table
Insight Molecular Diagnostics Inc. SEC filings
Insight Molecular Diagnostics Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of OCX - Oncocyte Corporation - Common Shares, No Par Value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Patrick W. Smith
Disclosed value leader
BROADWOOD CAPITAL INC
Comparable rows
15/15
Latest evidence
26 Dec 2024
13D/G
13F
3/4/5
Lead comparable stake: 10%
13D/G row: Patrick W. Smith
Showing 1-6 of 15 holder rows.
Quick read
Patrick W. Smith leads the comparable SEC ownership view at 10%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Patrick W. Smith's linked filing trail.
Comparable ownership
Top 5
Patrick W. Smith
10%
BROADWOOD CAPITAL INC
15%
AWM Investment Company, Inc.
3.4%
PURA VIDA INVESTMENTS, LLC
1.5%
VANGUARD GROUP INC
0.76%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Patrick W. Smith |
13D/G
|
10%
|
$4,221,889
1,773,903 shares
|
$0 | 26 Dec 2024 |
| BROADWOOD CAPITAL INC |
13F
Company
|
15%
|
$14,047,838
4,929,066 shares
|
— | 30 Sep 2024 |
| AWM Investment Company, Inc. |
13F
Company
|
3.4%
|
$3,126,949
1,097,175 shares
|
— | 30 Sep 2024 |
| PURA VIDA INVESTMENTS, LLC |
3/4/5
13F
10%+ Owner · Company
|
1.5%
from 13F
|
$3,044,309
16,591,052 shares
mixed-class rows
|
— | 14 Apr 2023 |
| VANGUARD GROUP INC |
13F
Company
|
0.76%
|
$699,356
245,388 shares
|
— | 30 Sep 2024 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.32%
|
$296,400
103,980 shares
|
— | 30 Sep 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
47,078
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
1
Q4 2024 holders
1
Holder diff
0
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 value | Q4 2024 value | Value change | Value Chg % |
|---|